47.73.Z - Retail sale of pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.49.Z - Wholesale trade of other household articles
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0,1 | 0,2 | 50,1 |
Gross profit (loss) | 0,2 | 0,1 | 0,2 | 52,5 |
EBITDA | 0,2 | 0,1 | 0,2 | 52,5 |
Short time liabilities | 0,2 | 0,2 | 0,2 | 4,2 |
Other operating costs | 0 | 0 | 0 | -50,6 |
Equity capital | 0,3 | 0,3 | 0,3 | 26,3 |
Operating profit (EBIT) | 0,2 | 0,1 | 0,2 | 52,5 |
Assets | 0,5 | 0,5 | 0,6 | 14,2 |
Net profit (loss) | 0,2 | 0,1 | 0,2 | 52,5 |
Cash | 0,2 | 0,2 | 0,3 | 18,7 |
Net income from sale | 2,8 | 3 | 3,4 | 14,4 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,3 | 3,1 |
Working assets | 0,5 | 0,5 | 0,6 | 14,2 |
Other income costs | 0 | 0 | 0 | 47,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 61,5 | 50,1 | 60,5 | 10,4 |
Equity capital to total assets | 58,4 | 47,9 | 52,9 | 5 |
Gross profit margin | 7,2 | 4,7 | 6,3 | 1,6 |
EBITDA Margin | 6 | 4,7 | 6,3 | 1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 24 | 29 | 27 | -2 |
Current financial liquidity indicator | 2.7680106163024902 | 2.198878765106201 | 2.4095101356506348 | 0,2 |
Net dept to EBITDA | -1.4136979579925537 | -1.6039103269577026 | -1.2657675743103027 | 0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane